Definition
Cathepsin D is an aspartic protease enzyme primarily localized within lysosomes, where it participates in the degradation of intracellular proteins.
Overview
Cathepsin D is encoded by the CTSD gene in humans and is expressed in a wide variety of tissues. As a member of the peptidase A1 family, it functions optimally at acidic pH and contributes to normal cellular turnover, antigen processing, and programmed cell death (apoptosis). Dysregulation of cathepsin D activity has been associated with several pathological conditions, including neurodegenerative diseases, certain cancers, and lysosomal storage disorders. The enzyme is synthesized as an inactive precursor (preprocathepsin D), which undergoes proteolytic processing in the Golgi apparatus and subsequent activation within the acidic environment of the lysosome.
Etymology/Origin
The name “cathepsin” derives from the Greek word kathéptein (καθεπτειν), meaning “to digest.” The suffix “D” distinguishes this isoform from other cathepsins (e.g., cathepsin B, L, S) based on its order of discovery and classification within the aspartic protease subgroup.
Characteristics
| Feature | Description |
|---|---|
| Enzyme classification | EC 3.4.23.5 (Aspartic endopeptidase) |
| Gene | CTSD (located on chromosome 11p15.5) |
| Molecular weight | Approximately 48–55 kDa (mature form) |
| Structure | Single polypeptide chain that folds into a bilobal architecture typical of aspartic proteases; contains two essential aspartic acid residues in the active site. |
| Optimal pH | ~4.5–5.0 (lysosomal environment) |
| Substrate specificity | Broad; cleaves peptide bonds adjacent to hydrophobic residues, especially phenylalanine, leucine, and tyrosine. |
| Physiological roles | Protein catabolism, processing of prohormones, activation of other proteases, regulation of apoptosis, and participation in autophagic pathways. |
| Pathological associations | Overexpression in breast, prostate, and lung cancers; involvement in Alzheimer’s disease amyloid‑β peptide processing; mutations cause congenital neuronal ceroid lipofuscinosis (a lysosomal storage disorder). |
| Inhibition | Inhibited by specific aspartic protease inhibitors (e.g., pepstatin A) and by certain synthetic small‑molecule drugs under investigation for therapeutic applications. |
Related Topics
- Lysosome – organelle where cathepsin D is predominantly active.
- Aspartic proteases – enzyme family that includes pepsin, renin, and other cathepsins.
- Apoptosis – programmed cell death pathway in which cathepsin D can act as a pro‑apoptotic factor.
- Cathepsin family – broader group of lysosomal proteases (e.g., cathepsins B, L, S, K).
- Neurodegenerative diseases – conditions such as Alzheimer’s disease where cathepsin D activity influences protein aggregation.
- Cancer biomarkers – cathepsin D levels are investigated as potential prognostic indicators in various malignancies.